Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02782039

Acronym

SAPL-LUPUS

Enrollment

868

Registered

2016-05-25

Start date

2017-05-17

Completion date

2022-03-31

Last updated

2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-Phospholipids Syndrome (APS), Systemic Lupus Erythematosus (SLE)

Brief summary

The purpose of that register is to collect medical information about patients suffering of APS with or without associated SLE.

Detailed description

Recruitment of patients with APS and SLE treated. Retrospective and prospective register.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient with APS * Patient with SLE

Exclusion criteria

* Dependent person * Hospitalized without consent and not protected by law * Detainee

Design outcomes

Primary

Measure	Time frame
Number of patients enrolled with Anti-Phospholipids syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)	5 years

Countries

France

Outcome results